Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis
NCT07712705Phase 3Completed
- Sponsor
- Newsoara Biopharma
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
A Phase 3 trial of HPP737 in plaque psoriasis, sponsored by Newsoara Biopharma. Started Apr 2023; status: completed.
02
Drugs
HPP737
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07712705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712705.